Further, previous studies have shown that activation of OX2R within the orexin system increases wakefulness in wild-type mice [17], as well as in people with NT2 [27] or sleep apnea [20] with normal orexin concentrations, suggesting these drugs are effective even when orexin system neurons are not damaged. This evidence concerns the gene HCRTR2 and sleep apnea syndrome.